Cal-Maine Foods Reaches Resolution with U.S. Department of Justice and 17 States’ Attorneys General
GlobeNewswire Inc.
1 hours ago
RIDGELAND, Miss., June 29, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (“Cal-Maine” or “the Company”) (Nasdaq: CALM) today announced that it has reached an agreement to resolve the claims of the U.S. Department of Justice (DOJ) and 17 states' atto
Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock
GlobeNewswire Inc.
1 hours ago
FORT LEE, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative therapies for the treatment of immune complement-related conditions and oncolo
Vishay Intertechnology Announces Pricing of Public Offering of Common Stock
GlobeNewswire Inc.
1 hours ago
MALVERN, Pa., June 29, 2026 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (the “Company,” “Vishay”) (NYSE: VSH) today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a price to the public of $50
WordSearchZen.com Expands Open-Access Educational Utilities Amid Rising Demand for Printable Learning Materials
Newsfile
2 hours ago
Melbourne, Australia--(Newsfile Corp. - June 29, 2026) - Digital puzzle platform WordSearchZen.com has finalized a strategic expansion of its open-access educational repository through the deployment of a browser-based word search maker. The launch m
Bengal Energy Provides Update on Ramses 2 Oil Well - Retains 100% Interest and Advances Self-Funded Production Test Plan
Newsfile
2 hours ago
Calgary, Alberta--(Newsfile Corp. - June 29, 2026) - Bengal Energy Ltd. (TSX: BNG) ("Bengal" or the "Company") announces that discussions have terminated and the Company will not be proceeding with binding documentation under the non-binding Letter o
Kexing Biopharm's TL1A/LIGHT Bispecific Antibody Presents at 2026 BFC-Cytiva Global Healthcare Summer BD & Investment Conference
Newsfile
2 hours ago
San Diego, California--(Newsfile Corp. - June 29, 2026) - Recently, the Head of Global Business Development at Kexing Biopharm Co., Ltd. (hereinafter referred to as "Kexing Biopharm", 688136.SH) was invited to attend the 2026 BFC-Cytiva Global Health
Mama’s Creations Announces Pricing of $100 Million Public Offering of Common Stock
GlobeNewswire Inc.
3 hours ago
EAST RUTHERFORD, New Jersey, June 29, 2026 (GLOBE NEWSWIRE) -- Mama’s Creations, Inc. (Nasdaq: MAMA) (“Mama’s Creations” or the “Company”), a leading national marketer and manufacturer of fresh deli prepared foods, today announced the pricing of its
MiMedia Holdings Inc. Reports Voting Results from Annual General and Special Meeting
Newsfile
3 hours ago
New York, New York--(Newsfile Corp. - June 29, 2026) - MiMedia Holdings Inc. (TSXV: MIM) (OTCQB: MIMDF) (FSE: KH3) ("MiMedia" or the "Company") is pleased to announce the voting results from the Company's Annual General and Special Meeting of the Sha
Lion One Announces Closing of First Tranche of Non-Brokered Private Placement of Convertible Debenture Units and Units for Gross Proceeds of $15.3 Million
Newsfile
3 hours ago
North Vancouver, British Columbia--(Newsfile Corp. - June 29, 2026) - Lion One Metals Limited (TSXV: LIO) (OTCQX: LOMLF) ("Lion One" or the "Company") is pleased to announce that it has closed the first tranche of its previously announced non-brokere
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2
GlobeNewswire Inc.
5 hours ago
ZORYVE cream 0.3% is the first once-daily, non-steroidal therapy approved for children with plaque psoriasis as young as 2 years of ageZORYVE cream 0.3% is safe, effective, and well-tolerated for use anywhere on the body with no restrictions on durat

